- Home
- LTRX vs PALI Comparison
LTRX vs PALI Comparison
Compare LTRX & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- PALI
- Stock Information
- Founded
- LTRX 1989
- PALI 1996
- Country
- LTRX United States
- PALI United States
- Employees
- LTRX N/A
- PALI N/A
- Industry
- LTRX Computer Communications Equipment
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTRX Telecommunications
- PALI Health Care
- Exchange
- LTRX Nasdaq
- PALI Nasdaq
- Market Cap
- LTRX 199.5M
- PALI 212.0M
- IPO Year
- LTRX 2000
- PALI N/A
- Fundamental
- Price
- LTRX $5.00
- PALI $2.24
- Analyst Decision
- LTRX Strong Buy
- PALI Strong Buy
- Analyst Count
- LTRX 3
- PALI 1
- Target Price
- LTRX $5.17
- PALI $16.00
- AVG Volume (30 Days)
- LTRX 249.6K
- PALI 3.9M
- Earning Date
- LTRX 11-05-2025
- PALI 11-10-2025
- Dividend Yield
- LTRX N/A
- PALI N/A
- EPS Growth
- LTRX N/A
- PALI N/A
- EPS
- LTRX N/A
- PALI N/A
- Revenue
- LTRX $118,294,000.00
- PALI N/A
- Revenue This Year
- LTRX $4.77
- PALI N/A
- Revenue Next Year
- LTRX $11.90
- PALI N/A
- P/E Ratio
- LTRX N/A
- PALI N/A
- Revenue Growth
- LTRX N/A
- PALI N/A
- 52 Week Low
- LTRX $1.91
- PALI $0.53
- 52 Week High
- LTRX $5.74
- PALI $3.30
- Technical
- Relative Strength Index (RSI)
- LTRX 54.17
- PALI 58.76
- Support Level
- LTRX $4.45
- PALI $2.11
- Resistance Level
- LTRX $4.88
- PALI $2.45
- Average True Range (ATR)
- LTRX 0.26
- PALI 0.23
- MACD
- LTRX 0.00
- PALI 0.01
- Stochastic Oscillator
- LTRX 55.88
- PALI 77.01
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.